| Metric | შპს ჯიჰელსი | შპს ნეოფარმი + | შპს მედელ საქართველო |
|---|---|---|---|
| Growth | |||
| Revenue | ₾15.6m₾11.1m | ₾16.3m₾13.9m | ₾16.3m₾5.3m |
| Revenue growth | 40.1% | 17.4% | 206.5% |
| Profitability | |||
| EBITDA | ₾5.1m₾931k | -₾751k-₾1.2m | ₾5.6m₾2.2m |
| EBITDA margin | 32.5%8.4% | -4.6%-8.4% | 34.0%41.9% |
| Net profit | ₾5.2m₾1.5m | -₾873k-₾1.3m | ₾5.5m₾2.2m |
| Net margin | 33.2%13.7% | -5.4%-9.1% | 33.5%41.9% |
| Balance sheet | |||
| Total assets | ₾5.3m₾1.0m | ₾5.7m₾6.3m | ₾2.2m₾233k |
| Total equity | ₾3.4m₾560k | ₾14k₾887k | ₾797k₾15k |
| ROE | 151.4%272.3% | -6150.6%-142.2% | 685.3%15402.6% |